These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38456672)

  • 1. Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction.
    Boyd LF; Jiang J; Ahmad J; Natarajan K; Margulies DH
    J Immunol; 2024 Apr; 212(8):1366-1380. PubMed ID: 38456672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental structures of antibody/MHC-I complexes reveal details of epitopes overlooked by computational prediction.
    Boyd LF; Jiang J; Ahmad J; Natarajan K; Margulies DH
    bioRxiv; 2023 Dec; ():. PubMed ID: 38106040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First.
    Wu Y; Zhang N; Hashimoto K; Xia C; Dijkstra JM
    Front Immunol; 2021; 12():621153. PubMed ID: 34194421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Glimpse of the Peptide Profile Presentation by
    Ma L; Zhang N; Qu Z; Liang R; Zhang L; Zhang B; Meng G; Dijkstra JM; Li S; Xia MC
    J Immunol; 2020 Jan; 204(1):147-158. PubMed ID: 31776204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Structure of a Peptide-Loaded Shark MHC Class I Molecule Reveals Features of the Binding between β
    Wu Y; Zhang N; Wei X; Lu S; Li S; Hashimoto K; Dijkstra JM; Xia C
    J Immunol; 2021 Jul; 207(1):308-321. PubMed ID: 34145057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PANDORA v2.0: Benchmarking peptide-MHC II models and software improvements.
    Parizi FM; Marzella DF; Ramakrishnan G; 't Hoen PAC; Karimi-Jafari MH; Xue LC
    Front Immunol; 2023; 14():1285899. PubMed ID: 38143769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pDOCK: a new technique for rapid and accurate docking of peptide ligands to Major Histocompatibility Complexes.
    Khan JM; Ranganathan S
    Immunome Res; 2010 Sep; 6 Suppl 1(Suppl 1):S2. PubMed ID: 20875153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Prediction of Peptide-MHC Binding Modes.
    Perez MAS; Cuendet MA; Röhrig UF; Michielin O; Zoete V
    Methods Mol Biol; 2022; 2405():245-282. PubMed ID: 35298818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PANDORA: A Fast, Anchor-Restrained Modelling Protocol for Peptide: MHC Complexes.
    Marzella DF; Parizi FM; van Tilborg D; Renaud N; Sybrandi D; Buzatu R; Rademaker DT; 't Hoen PAC; Xue LC
    Front Immunol; 2022; 13():878762. PubMed ID: 35619705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPID-T: database for sequence-structure-function information on T-cell receptor/peptide/MHC interactions.
    Tong JC; Kong L; Tan TW; Ranganathan S
    Appl Bioinformatics; 2006; 5(2):111-4. PubMed ID: 16722775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the immunoregulatory receptor LILRB1 as a crystallisation chaperone for human class I MHC complexes.
    Mohammed F; Stones DH; Willcox BE
    J Immunol Methods; 2019 Jan; 464():47-56. PubMed ID: 30365927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production and identification of the monoclonal antibodies specific for MHC class I complexes bound with HPV16E7 CTL epitopic peptide.].
    Yin R; Hao F; Zhong BY; Li QJ; Li AX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Sep; 20(3):257-9. PubMed ID: 17086287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
    Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors.
    Macdonald IK; Harkiolaki M; Hunt L; Connelley T; Carroll AV; MacHugh ND; Graham SP; Jones EY; Morrison WI; Flower DR; Ellis SA
    PLoS Pathog; 2010 Oct; 6(10):e1001149. PubMed ID: 20976198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
    Meyer M; Parpoulas C; Barthélémy T; Becker JP; Charoentong P; Lyu Y; Börsig S; Bulbuc N; Tessmer C; Weinacht L; Ibberson D; Schmidt P; Pipkorn R; Eichmüller SB; Steinberger P; Lindner K; Poschke I; Platten M; Fröhling S; Riemer AB; Hassel JC; Roberti MP; Jäger D; Zörnig I; Momburg F
    Front Immunol; 2023; 14():1294565. PubMed ID: 38239352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement with the TCR induces plasticity in antigenic ligands bound to MHC class I and CD1 molecules.
    Morita D; Asa M; Sugita M
    Int Immunol; 2023 Jan; 35(1):7-17. PubMed ID: 36053252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Newly Recognized Pairing Mechanism of the α- and β-Chains of the Chicken Peptide-MHC Class II Complex.
    Zhang L; Li X; Ma L; Zhang B; Meng G; Xia C
    J Immunol; 2020 Mar; 204(6):1630-1640. PubMed ID: 32034060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.
    Sullivan LC; Berry R; Sosnin N; Widjaja JM; Deuss FA; Balaji GR; LaGruta NL; Mirams M; Trapani JA; Rossjohn J; Brooks AG; Andrews DM
    J Biol Chem; 2016 Sep; 291(36):18740-52. PubMed ID: 27385590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody that distinguishes between a phosphorylated, beta 2-microglobulin-associated, and a free, nonphosphorylated, chain of MHC class I.
    Thor G; Sepulveda H; Chada S; Dutton RW
    J Immunol; 1993 Jul; 151(1):211-24. PubMed ID: 7686933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
    Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
    Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.